Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2017-04-27 Earnings Release
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
170425 Biocartis Q1 2017 business update_ENG_FINAL.pdf
Earnings Release Classification · 95% confidence The document is a 'Q1 2017 Business Update' press release from Biocartis. It provides a summary of commercial performance, regulatory updates, menu expansion, and financial highlights (such as cash position and grants) for the first quarter. While it contains financial data, it is a high-level summary release rather than a comprehensive interim financial report (which would include full financial statements). According to the filing definitions, this type of periodic business update/earnings-related release is classified as an Earnings Release (ER). Q1 2017
2017-04-27 English
170425 Biocartis Q1 2017 business update_NL_FINAL.pdf
Earnings Release Classification · 98% confidence The document is explicitly titled "PERSBERICHT GEREGLEMENTEERDE INFORMATIE" (Regulated Information Press Release) and provides a "BIOCARTIS Q1 2017 BUSINESS UPDATE." It details commercial progress, regulatory updates (FDA, CE-marking timelines), menu expansion, and a financial update for the first quarter (Q1 2017). This structure—a press release summarizing key operational and financial highlights for a specific interim period (Q1)—is characteristic of an Earnings Release (ER). It is not the full, comprehensive Interim Report (IR) itself, nor is it a transcript (CT) or a formal Annual Report (10-K). The document also contains a financial calendar mentioning the upcoming H1 2017 results and AGM, confirming its nature as a periodic update preceding the full interim report. Q1 2017
2017-04-27 Dutch
20170421 Transp notif Sycomore Asset Mgt ENG FINAL.pdf
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled a 'PRESS RELEASE REGULATED INFORMATION' and announces the 'Disclosure of a transparency notification' regarding a major shareholding change (Sycomore Asset Management crossing the 5% threshold) under the Belgian Act of 2 May 2007. This type of filing, which reports changes in significant ownership stakes, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a press release, the core content is the notification itself, making MRQ more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA). The document length (6181 chars) is substantial enough to contain the full details of the notification, not just an announcement of an attachment.
2017-04-21 English
20170421 Transp notif Sycomore Asset Mgt NL FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled 'PERSBERICHT GEREGLEMENTEERDE INFORMATIE' (Regulated Information Press Release) and announces the receipt of a 'transparantiekennisgeving' (transparency notification) regarding a change in significant shareholding, specifically Sycomore Asset Management crossing the 5% threshold according to Belgian law (Wet van 2 mei 2007). This type of filing, which reports changes in major share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is presented as a press release, the core content is the mandatory disclosure of a significant ownership change, not just an announcement of a report (RPA) or a general regulatory filing (RNS).
2017-04-21 Dutch
AGM 2017 - Vote by mail (DUT) (final).pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is titled "FORMULIER VOOR STEMMING PER BRIEF" (Proxy Voting Form) for the "GEWONE ALGEMENE VERGADERING" (Ordinary General Meeting) scheduled for May 12, 2017. It explicitly details the procedures for shareholders to cast their votes by mail/proxy on various agenda items, including the approval of annual accounts (for the year ended December 31, 2016), discharge of directors, and reappointment/confirmation of directors and remuneration policies. This content is the core material used to solicit shareholder votes for a general meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it mentions annual reports (items 1-3), the document itself is the mechanism for voting on those reports, not the report itself.
2017-04-11 Dutch
AGM 2017 - Proxy (DUT) (final).pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled "VOLMACHT" (Proxy/Power of Attorney) and explicitly refers to the "GEWONE ALGEMENE VERGADERING" (Ordinary General Meeting) scheduled for May 12, 2017. It contains detailed instructions on how shareholders can appoint a proxy holder to vote on agenda items, which include the approval of annual accounts, discharge of directors, and reappointment of directors. This material is directly related to soliciting shareholder votes and providing information ahead of the AGM. This strongly aligns with the definition of Proxy Solicitation & Information Statement (PSI). While it relates to the AGM, it is the proxy form itself, not the AGM presentation (AGM-R) or the formal notice/results (DEF 14A/DVA).
2017-04-11 Dutch

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.